Journal article
Evaluating Variation in Lymph Node Sampling During Sentinel Lymph Node Biopsy for Melanoma
Annals of surgical oncology, Vol.32(13), pp.9660-9667
12/2025
DOI: 10.1245/s10434-025-18063-5
PMCID: PMC12589253
PMID: 40819148
Abstract
The operative standard for melanoma, implemented by the Commission on Cancer (CoC), addresses margin width and excision depth, but does not collect information on sentinel lymph node biopsy (SLNB). However, SLNB, an implemented technical standard in breast cancer, is also critical in the management of melanoma through its impact on nodal staging. This study aimed to characterize the current facility-level variation in nodal yield and nodal positivity to determine if there is an opportunity for improvement through standardization.
Using the National Cancer Database, we identified patients with T1b-T4 melanoma of the trunk and upper extremities who underwent SLNB from 2018 to 2022. Reliability-adjusted estimates for nodal yield and nodal positivity were calculated using Poisson regression and logistic regression with random intercepts for hospitals.
We identified 48,653 melanoma patients from 1167 facilities. SLNB median nodal yield was 2.4 (IQR 2.2-2.7), ranging from 1.4 to 7.0. SLNB median nodal positivity was 18.0% (IQR 17.1-19.5%), ranging from 11.6 to 40.5%. A weak correlation between nodal yield and nodal positivity was observed (Spearman correlation coefficient = 0.08, p = 0.009).
Facility-level variation in nodal yield was minimal and weakly correlated with nodal positivity. This suggests that SLNB performed for melanoma of the trunk and upper extremities is well standardized across CoC hospitals in the absence of a defined operative standard. Future efforts to improve the quality of melanoma nodal surgery may be best focused on technical elements of other procedures, such as lymphadenectomy or more novel lymph node dissection approaches following neoadjuvant therapy.
Details
- Title: Subtitle
- Evaluating Variation in Lymph Node Sampling During Sentinel Lymph Node Biopsy for Melanoma
- Creators
- Crystal D Taylor - Michigan MedicineVanessa S Niba - Michigan MedicineAlison S Baskin - University of California, San FranciscoNicole M Mott - University of MichiganErin Kim - University of MichiganAbigail Kappelman - University of MichiganTon Wang - Duke UniversityBrandy R Sinco - Michigan MedicineAmanda B Francescatti - American College of SurgeonsDaniel J Boffa - Yale UniversitySamantha Hendren - Indiana University – Purdue University IndianapolisJudy C Boughey - American College of SurgeonsTina J Hieken - American College of SurgeonsRonald J Weigel - University of IowaTasha M Hughes - Michigan MedicineLesly A Dossett - Michigan Medicine
- Resource Type
- Journal article
- Publication Details
- Annals of surgical oncology, Vol.32(13), pp.9660-9667
- DOI
- 10.1245/s10434-025-18063-5
- PMID
- 40819148
- PMCID
- PMC12589253
- NLM abbreviation
- Ann Surg Oncol
- ISSN
- 1068-9265
- eISSN
- 1534-4681
- Publisher
- SPRINGER
- Grant note
- T32 CA236621 / NCI NIH HHS R01 CA288625 / NCI NIH HHS
- Language
- English
- Electronic publication date
- 08/16/2025
- Date published
- 12/2025
- Academic Unit
- Molecular Physiology and Biophysics; Anatomy and Cell Biology; Surgery; Biochemistry and Molecular Biology
- Record Identifier
- 9984948002702771
Metrics
7 Record Views